biomarker-driven trials of anticoagulants vs antiplatelets for secondary stroke prevention
Published 2 years ago • 140 plays • Length 3:45Download video MP4
Download video MP3
Similar videos
-
5:30
blood biomarkers to guide secondary stroke prevention with anticoagulation
-
3:39
developing blood-based biomarkers for stroke
-
1:48
expedited recommendation for short-term dual antiplatelet therapy after minor stroke & high-risk tia
-
5:30
pharmacology: anticoagulants, animation
-
1:11
biomarkers driving precision medicine in stroke
-
17:51
antiplatelet and anticoagulant strategies: evidence
-
47:22
novel anticoagulants and antiplatelet agents- dr. stuart christenson, 2/21/13
-
4:26
stroke antiplatelets and improving anticoagulation
-
4:31
biomarkers of cardiac thrombogenicity to distinguish cardioembolic and atherothrombotic stroke risk
-
5:54
combining antiplatelet and anticoagulant therapies
-
3:04
podcast 555: anticoagulation vs. antiplatelet
-
13:42
anticoagulation and stroke prevention (amish dave, md)
-
1:58
therapeutic agents being explored in waldenström’s macroglobulinemia trials
-
3:34
anticoagulation in vt
-
17:45
anticoagulation/stroke prevention (miguel valderrábano, md)
-
13:42
anticoagulation and stroke prevention (amish dave, md)
-
9:14
the role of vascular surgeon in stroke prevention - b rantner
-
3:02
advancing diagnostic biomarkers for cardiovascular disease